These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7023224)

  • 61. Strategies for reversing shock-resistant ventricular fibrillation.
    Sarkozy A; Dorian P
    Curr Opin Crit Care; 2003 Jun; 9(3):189-93. PubMed ID: 12771668
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The effect of newer antiarrhythmic drugs on defibrillation threshold.
    Tacker WA; Niebauer MJ; Babbs CF; Combs WJ; Hahn BM; Barker MA; Seipel JF; Bourland JD; Geddes LA
    Crit Care Med; 1980 Mar; 8(3):177-80. PubMed ID: 7363635
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Successful long-term suppression of previously refractory paroxysmal ventricular tachycardia with bretylium tosylate.
    Slack JD; Rizk AE; Wright KE
    Heart Lung; 1979; 8(4):721-7. PubMed ID: 378903
    [No Abstract]   [Full Text] [Related]  

  • 64. Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest.
    Kudenchuk PJ; Brown SP; Daya M; Rea T; Nichol G; Morrison LJ; Leroux B; Vaillancourt C; Wittwer L; Callaway CW; Christenson J; Egan D; Ornato JP; Weisfeldt ML; Stiell IG; Idris AH; Aufderheide TP; Dunford JV; Colella MR; Vilke GM; Brienza AM; Desvigne-Nickens P; Gray PC; Gray R; Seals N; Straight R; Dorian P;
    N Engl J Med; 2016 May; 374(18):1711-22. PubMed ID: 27043165
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Bretylium tosylate for suppression of induced ventricular fibrillation.
    Bacaner M
    Am J Cardiol; 1966 Apr; 17(4):528-34. PubMed ID: 5929660
    [No Abstract]   [Full Text] [Related]  

  • 66. Antiarrhythmic Drugs for Nonshockable-Turned-Shockable Out-of-Hospital Cardiac Arrest: The ALPS Study (Amiodarone, Lidocaine, or Placebo).
    Kudenchuk PJ; Leroux BG; Daya M; Rea T; Vaillancourt C; Morrison LJ; Callaway CW; Christenson J; Ornato JP; Dunford JV; Wittwer L; Weisfeldt ML; Aufderheide TP; Vilke GM; Idris AH; Stiell IG; Colella MR; Kayea T; Egan D; Desvigne-Nickens P; Gray P; Gray R; Straight R; Dorian P;
    Circulation; 2017 Nov; 136(22):2119-2131. PubMed ID: 28904070
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Quantitiative comparison of bretylium with other antifibrillatory drugs.
    Bacaner MB
    Am J Cardiol; 1968 Apr; 21(4):504-12. PubMed ID: 5650730
    [No Abstract]   [Full Text] [Related]  

  • 68. Treatment of ventricular fibrillation and other acute arrhythmias with bretylium tosylate.
    Bacaner MB
    Am J Cardiol; 1968 Apr; 21(4):530-43. PubMed ID: 5650734
    [No Abstract]   [Full Text] [Related]  

  • 69. Advanced cardiac life support controversy: where do antiarrhythmic agents fit in?
    Chow MS
    Pharmacotherapy; 1997; 17(2 Pt 2):84S-88S; discussion 89S-91S. PubMed ID: 9085344
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Drug treatment of arrhythmias during cardiopulmonary resuscitation. A statement for the Advanced Life Support Working Party of the European Resuscitation Council.
    von Planta M; Chamberlain D
    Resuscitation; 1992 Dec; 24(3):227-32. PubMed ID: 1336883
    [No Abstract]   [Full Text] [Related]  

  • 71. Drug corner: bretylium tosylate (Bretylol).
    Crit Care Nurse; 1980; 1(1):68-9. PubMed ID: 6914232
    [No Abstract]   [Full Text] [Related]  

  • 72. [The effect of bretylium tosylate on ventricular arrhythmias in patients with acute myocardial infarction].
    Kochmański M; Rdzanek H; Zochowski RJ
    Pol Tyg Lek; 1992 Oct 5-12; 47(40-41):901-4. PubMed ID: 1341893
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Bretylium tosylate for cardiopulmonary arrest.
    White RD
    Ann Emerg Med; 1981 Oct; 10(10):548. PubMed ID: 7283224
    [No Abstract]   [Full Text] [Related]  

  • 74. Treatment of refractory ventricular arrhythmias. High dose parenteral and oral bretylium tosylate.
    Noneman JW; Batenhorst RL; Jones MR; Garrett ER; Foster TS
    Chest; 1982 Apr; 81(4):517-9. PubMed ID: 7067521
    [No Abstract]   [Full Text] [Related]  

  • 75. [Bretylium tosylate as an anti-arrhythmic drug].
    Steffen V; Fiehring H
    Z Gesamte Inn Med; 1976 Nov; 31(22):913-9. PubMed ID: 798429
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Treatment of paroxysmal disorders of cardiac rhythm].
    Zamfir C; Turcu E
    Med Interna (Bucur); 1972 Dec; 24(12):1425-34. PubMed ID: 4144091
    [No Abstract]   [Full Text] [Related]  

  • 77. Comprehensive treatment plan for the prevention of primary ventricular fibrillation in acute myocardial infarction.
    Wyman MG; Hammersmith L
    Am J Cardiol; 1974 May; 33(5):661-7. PubMed ID: 4820897
    [No Abstract]   [Full Text] [Related]  

  • 78. [Bretylium tosylate and ventricular hyperexcitability in myocardial infarct].
    Torresani J; Delaage M
    G Ital Cardiol; 1972; 2(1):163. PubMed ID: 5012000
    [No Abstract]   [Full Text] [Related]  

  • 79. [Pharmacotherapy of ventricular fibrillation. A prospective study in an emergency medical service].
    Schüttler J; Bremer F; Hörnchen U
    Anaesthesist; 1991 Mar; 40(3):172-9. PubMed ID: 2035822
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Amiodarone versus lidocaine and placebo for the prevention of ventricular fibrillation after aortic crossclamping: a randomized, double-blind, placebo-controlled trial.
    Mauermann WJ; Pulido JN; Barbara DW; Abel MD; Li Z; Meade LA; Schaff HV; White RD
    J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1229-34. PubMed ID: 22770549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.